Conduit acquires three first-in-class assets from AstraZeneca - Pharmaceutical Technology

Retrieved on: 2024-08-08 16:53:07

Tags for this article:

Click the tags to see associated articles and topics

Conduit acquires three first-in-class assets from AstraZeneca - Pharmaceutical Technology. View article details on hiswai:

Summary

The article discusses Conduit Pharmaceuticals’ acquisition of assets from AstraZeneca, highlighting their potential for metabolic and autoimmune disorders treatment. Tags and key concepts underscore the strategic business intelligence applied in pharmaceutical research and development.

Article found on: www.pharmaceutical-technology.com

View Original Article